BACKGROUND: Although the Fisher scale is commonly used to grade vasospasm risk in aneurysmal subarachnoid hemorrhage (aSAH) patients, it fails to account for increasing subarachnoid hemorrhage (SAH) thickness. OBJECTIVE: We developed a simple quantitative scale based on maximal SAH thickness and compared its reproducibility and ability to predict symptomatic vasospasm against the Fisher scale. METHODS: The incidence of radiographic and symptomatic vasospasm among 250 aSAH patients treated at our institution was investigated. Admission head computed tomography scans were graded according to the Fisher scale and the proposed scale, which assigns a score from 1 to 5 based on a single measurement of maximum SAH thickness. We calculated vasospasm risk per grade for the Fisher scale and the proposed scale, and compared inter- and intraobserver variability for both scales. RESULTS: Forty-five patients (20.6%) developed symptomatic vasospasm. On the proposed scale, grade 5 patients were at highest risk, with an odds ratio for symptomatic vasospasm of 11 (95% confidence interval [CI] 2.27-53.37). Odds ratios for proposed grades 4 and 3 were 4.63 (95% CI 1.10-19.59) and 3.04 (95% CI 0.85-10.90), respectively. The odds ratio for Fisher grade 3 was 3.3 (0.96-11.30). Mean inter- and intraobserver agreement was greater for the proposed scale in comparison with the Fisher scale (κ0.65 and κ0.81 vs κ0.51 and κ0.35, respectively). CONCLUSION: The new scale accounted for increasing SAH thickness and was superior to the Fisher scale in inter- and intraobserver agreement and in predicting symptomatic vasospasm, particularly among the highest-risk patients.
BACKGROUND: Although the Fisher scale is commonly used to grade vasospasm risk in aneurysmal subarachnoid hemorrhage (aSAH) patients, it fails to account for increasing subarachnoid hemorrhage (SAH) thickness. OBJECTIVE: We developed a simple quantitative scale based on maximal SAH thickness and compared its reproducibility and ability to predict symptomatic vasospasm against the Fisher scale. METHODS: The incidence of radiographic and symptomatic vasospasm among 250 aSAH patients treated at our institution was investigated. Admission head computed tomography scans were graded according to the Fisher scale and the proposed scale, which assigns a score from 1 to 5 based on a single measurement of maximum SAH thickness. We calculated vasospasm risk per grade for the Fisher scale and the proposed scale, and compared inter- and intraobserver variability for both scales. RESULTS: Forty-five patients (20.6%) developed symptomatic vasospasm. On the proposed scale, grade 5 patients were at highest risk, with an odds ratio for symptomatic vasospasm of 11 (95% confidence interval [CI] 2.27-53.37). Odds ratios for proposed grades 4 and 3 were 4.63 (95% CI 1.10-19.59) and 3.04 (95% CI 0.85-10.90), respectively. The odds ratio for Fisher grade 3 was 3.3 (0.96-11.30). Mean inter- and intraobserver agreement was greater for the proposed scale in comparison with the Fisher scale (κ0.65 and κ0.81 vs κ0.51 and κ0.35, respectively). CONCLUSION: The new scale accounted for increasing SAH thickness and was superior to the Fisher scale in inter- and intraobserver agreement and in predicting symptomatic vasospasm, particularly among the highest-risk patients.
Authors: Wessel E van der Steen; Eva L Leemans; René van den Berg; Yvo B W E M Roos; Henk A Marquering; Dagmar Verbaan; Charles B L M Majoie Journal: Neuroradiology Date: 2019-01-28 Impact factor: 2.804
Authors: Azade Tabaie; Shamim Nemati; Jason W Allen; Charlotte Chung; Flavia Queiroga; Won-Jun Kuk; Adam B Prater Journal: AMIA Annu Symp Proc Date: 2020-03-04
Authors: Ivan Jovanović; Jakob Nemir; Danilo Gardijan; Milan Milošević; Zdravka Poljaković; Marijan Klarica; David Ozretić; Marko Radoš Journal: Neuroradiology Date: 2021-06-15 Impact factor: 2.804
Authors: Brian P Walcott; Anoop P Patel; Christopher J Stapleton; Rikin A Trivedi; Adam M H Young; Christopher S Ogilvy Journal: J Clin Neurosci Date: 2014-07-28 Impact factor: 1.961
Authors: A M Boers; I A Zijlstra; C S Gathier; R van den Berg; C H Slump; H A Marquering; C B Majoie Journal: AJNR Am J Neuroradiol Date: 2014-08-07 Impact factor: 3.825
Authors: Julia S Bretz; Falk Von Dincklage; Johannes Woitzik; Maren K L Winkler; Sebastian Major; Jens P Dreier; Georg Bohner; Michael Scheel Journal: Clin Neuroradiol Date: 2016-04-25 Impact factor: 3.649
Authors: Gregory Ehrlich; Thomas Kirschning; Holger Wenz; Aldemar Andres Hegewald; Eva Neumaier-Probst; Marcel Seiz-Rosenhagen Journal: In Vivo Date: 2019 Nov-Dec Impact factor: 2.155